+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Animal Blood Plasma Products & Derivatives Market - Global Forecast 2026-2032- Product Image
Animal Blood Plasma Products & Derivatives Market - Global Forecast 2026-2032- Product Image
New

Animal Blood Plasma Products & Derivatives Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 197 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5888590
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The animal blood plasma products and derivatives market is entering a pivotal phase, defined by technological innovation, evolving regulations, and new pressures across global supply chains. Senior decision-makers must grasp the complex forces at work to ensure future resilience and capitalize on strategic market opportunities.

Market Snapshot: Growth in the Animal Blood Plasma Products Market

The animal blood plasma products and derivatives market is experiencing steady growth, with expansion forecast from USD 1.63 billion in 2025 to USD 1.75 billion in 2026. Extended projections indicate a sustained compound annual growth rate (CAGR) of 7.99%, reaching USD 2.79 billion by 2032. This trajectory is driven by advanced purification methods, greater demand from medical, nutritional, and food sectors, and more rigorous quality standards across all core application areas. As the market matures, the interplay of supply constraints, regulatory changes, and technological advancement is reshaping the competitive landscape.

Scope & Segmentation of the Animal Blood Plasma Products Market

Our analysis offers a structured breakdown of the animal blood plasma products and derivatives ecosystem, clarifying how scientific trends, operational risks, and compliance pressures shape the market. The report covers segmentation and regional assessment across several dimensions relevant to executive strategy:

  • Species Sourcing: Avian, bovine, ovine, and porcine sources shape biochemical attributes, introduce supply limitations, and influence risk mitigation strategies for end users seeking differentiated raw materials.
  • Derivative Classes: Fetal bovine serum, fibrinogen, immunoglobulin, serum albumin, and thrombin present distinct roles in processing, unique performance characteristics, and must address varying degrees of oversight.
  • End-User Groups: Food manufacturers, pharmaceutical companies, and veterinary practices each require tailored plasma derivatives that align with their sector’s standards and procurement needs.
  • Application Use Cases: Animal feed, biomedical research, cell culture media, food processing, nutrition supplements, the pet food industry, pharmaceuticals and cosmetics, and tissue engineering—all reflect expanding requirements and customized applications.
  • Core Technologies: Fractionation, viral inactivation, analytical advancements, and adaptable manufacturing processes are necessary to support both bulk and high-precision product specifications.
  • Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific, each with varied regulatory requirements, sourcing profiles, and evolving buyer behaviors shaping regional positioning and compliance models.

Key Takeaways for Strategic Decision-Makers

  • Ongoing scientific progress continues to enhance the functions and potential uses of plasma derivatives, particularly within regenerative medicine and specialized cell culture solutions.
  • Regulatory changes are prompting higher compliance, with a growing need for integrated quality management, full product traceability, and safeguarded animal welfare throughout the supply chain.
  • Customizable production and processing flexibility are increasingly vital, as end-user expectations shift toward highly tailored and application-specific plasma formulations.
  • Effective market players succeed by blending scientific rigor, demonstrable product provenance, and agile sourcing approaches that swiftly address both compliance and market fluctuations.
  • Strategic collaborations—including partnerships with local suppliers and research organizations—help accelerate new product introductions, meet regional standards, and optimize distribution.
  • Technical differentiation, such as offering vertically integrated or specialized plasma derivatives, enhances the ability to cater to niche buyers and emerging use cases.

Tariff Impact Across the Animal Blood Plasma Value Chain

Tariff adjustments have redefined procurement strategies and reshaped operational footprints throughout the animal blood plasma products and derivatives sector. Industry stakeholders are increasingly adopting multisourcing, refining regional processing approaches, and implementing dynamic contract terms to reduce cost volatility. Enhanced supplier diversification and deeper collaborations are emerging as methods to improve compliance and mitigate trade-related uncertainties. This shift underscores a continued focus on resilience, especially within high-value and regulated applications.

Methodology & Data Sources for the Animal Blood Plasma Products Market

This report applies a multi-method approach: primary interviews with manufacturing, procurement, and technical stakeholders; critical literature review of scientific and trade publications; policy and tariff analysis through mid-2024; and close examination of recent industry disclosures. Triangulation and expert review processes underpin the results to ensure strategic accuracy and evidence validity.

Why This Report Matters for Animal Blood Plasma Products Decision-Makers

  • Empowers executives to make data-driven investment and sourcing decisions using actionable intelligence on regulation, technology, and supply chain dynamics in the animal blood plasma products market.
  • Reveals supply diversification tactics and regional positioning strategies to boost enterprise resilience amid market uncertainties.
  • Supports compliance initiatives and operational improvements through prioritized guidance tailored to evolving sector requirements and end-user standards.

Conclusion

Leaders navigating the animal blood plasma products and derivatives sector must adapt to continuous scientific developments and external pressures. Strategic planning, detailed market segmentation, and forward-looking compliance measures are central to advancing growth and maintaining resilience in this changing environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Animal Blood Plasma Products & Derivatives Market, by Animal Type
8.1. Avian
8.2. Bovine
8.3. Ovine
8.4. Porcine
9. Animal Blood Plasma Products & Derivatives Market, by Derivative Type
9.1. Fetal Bovine Serum
9.2. Fibrinogen
9.3. Immunoglobulin
9.4. Serum Albumin
9.5. Thrombin
10. Animal Blood Plasma Products & Derivatives Market, by End-User
10.1. Food Manufacturers
10.2. Pharmaceutical Companies
10.3. Veterinary
11. Animal Blood Plasma Products & Derivatives Market, by Application
11.1. Animal Feed
11.2. Biomedical Research
11.3. Cell Culture Media
11.4. Food Processing
11.5. Nutrition Supplements
11.6. Pet Food Industry
11.7. Pharmaceuticals & Cosmetics
11.8. Tissue Engineering
12. Animal Blood Plasma Products & Derivatives Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Animal Blood Plasma Products & Derivatives Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Animal Blood Plasma Products & Derivatives Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Animal Blood Plasma Products & Derivatives Market
16. China Animal Blood Plasma Products & Derivatives Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. ACROBiosystems Inc.
17.6. Alfa Laval Corporate AB
17.7. ANZCO Foods Limited
17.8. Auckland BioSciences Ltd.
17.9. BioChemed Services
17.10. Biowest Company
17.11. Bovogen Biologicals Pty Ltd.
17.12. Canvax Reagents S.L.
17.13. Ebrator Biochemicals Inc.
17.14. Kraeber & Co. GmbH
17.15. Lake Immunogenics, Inc.
17.16. LAMPIRE Biological Laboratories, Inc.
17.17. Meiji Holdings Co., Ltd.
17.18. Merck KGaA
17.19. Pel-Freez, LLC
17.20. Rockland Immunochemicals, Inc.
17.21. Rocky Mountain Biologicals
17.22. Scripps Laboratories, Inc.
17.23. Sigma-Aldrich
17.24. TCS Biosciences Ltd.
17.25. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY AVIAN, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY AVIAN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY AVIAN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BOVINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BOVINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BOVINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY OVINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY OVINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY OVINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PORCINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PORCINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PORCINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FETAL BOVINE SERUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FETAL BOVINE SERUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FETAL BOVINE SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FIBRINOGEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FIBRINOGEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FIBRINOGEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY IMMUNOGLOBULIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SERUM ALBUMIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SERUM ALBUMIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SERUM ALBUMIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY THROMBIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY THROMBIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY THROMBIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY VETERINARY, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY VETERINARY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY VETERINARY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BIOMEDICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BIOMEDICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY BIOMEDICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY CELL CULTURE MEDIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY CELL CULTURE MEDIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY CELL CULTURE MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY FOOD PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY NUTRITION SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY NUTRITION SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY NUTRITION SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PET FOOD INDUSTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PET FOOD INDUSTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PET FOOD INDUSTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS & COSMETICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS & COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS & COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. EUROPE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. EUROPE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 89. EUROPE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 90. EUROPE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 91. EUROPE ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 92. MIDDLE EAST ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. MIDDLE EAST ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 94. MIDDLE EAST ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 96. MIDDLE EAST ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 97. AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 99. AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 100. AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 101. AFRICA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. ASEAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. ASEAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 110. ASEAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 111. ASEAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 112. ASEAN ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. GCC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GCC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 115. GCC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 116. GCC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 117. GCC ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 118. EUROPEAN UNION ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. EUROPEAN UNION ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 120. EUROPEAN UNION ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 121. EUROPEAN UNION ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 122. EUROPEAN UNION ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. BRICS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. BRICS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 125. BRICS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 126. BRICS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 127. BRICS ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. G7 ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. G7 ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 130. G7 ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 131. G7 ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 132. G7 ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. NATO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. NATO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 135. NATO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 136. NATO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 137. NATO ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 140. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 141. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 142. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 143. UNITED STATES ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 144. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 145. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
TABLE 146. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY DERIVATIVE TYPE, 2018-2032 (USD MILLION)
TABLE 147. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 148. CHINA ANIMAL BLOOD PLASMA PRODUCTS & DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Animal Blood Plasma Products & Derivatives market report include:
  • ACROBiosystems Inc.
  • Alfa Laval Corporate AB
  • ANZCO Foods Limited
  • Auckland BioSciences Ltd.
  • BioChemed Services
  • Biowest Company
  • Bovogen Biologicals Pty Ltd.
  • Canvax Reagents S.L.
  • Ebrator Biochemicals Inc.
  • Kraeber & Co. GmbH
  • Lake Immunogenics, Inc.
  • LAMPIRE Biological Laboratories, Inc.
  • Meiji Holdings Co., Ltd.
  • Merck KGaA
  • Pel-Freez, LLC
  • Rockland Immunochemicals, Inc.
  • Rocky Mountain Biologicals
  • Scripps Laboratories, Inc.
  • Sigma-Aldrich
  • TCS Biosciences Ltd.
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.75 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.79 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Animal Blood Plasma Products and Derivatives - Global Strategic Business Report - Product Image

Animal Blood Plasma Products and Derivatives - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Animal Blood Product Market 2025-2029 - Product Image

Animal Blood Product Market 2025-2029

  • Report
  • 246 Pages
  • Global
From
Bioactive Peptide from Food Waste Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Bioactive Peptide from Food Waste Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 210 Pages
  • Global
From
Biological Membrane Vesicles: Scientific, Biotechnological and Clinical Considerations Part 2. Advances in Biomembranes and Lipid Self-Assembly Volume 33 - Product Image

Biological Membrane Vesicles: Scientific, Biotechnological and Clinical Considerations Part 2. Advances in Biomembranes and Lipid Self-Assembly Volume 33

  • Book
Botanicals and Natural Bioactives: Prevention and Treatment of Diseases - Product Image

Botanicals and Natural Bioactives: Prevention and Treatment of Diseases

  • Book
Copyright © 2002-2026 Research and Markets. All Rights Reserved.